Nobuo Tsukamoto

1.6k total citations
22 papers, 1.2k citations indexed

About

Nobuo Tsukamoto is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Nobuo Tsukamoto has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Nobuo Tsukamoto's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Nobuo Tsukamoto is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Nobuo Tsukamoto collaborates with scholars based in Japan, United States and Vietnam. Nobuo Tsukamoto's co-authors include Tadashi Yamamoto, Jun‐ichiro Inoue, Sakura Azuma, Norihiko Kobayashi, Chie Kudo‐Saito, Takaomi Ishida, Asuka Naito, Tomonori Yaguchi, Yutaka Kawakami and Yutaka Kawakami and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Nobuo Tsukamoto

20 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nobuo Tsukamoto

Since Specialization

Citations

This map shows the geographic impact of Nobuo Tsukamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Tsukamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Tsukamoto more than expected).

Fields of papers citing papers by Nobuo Tsukamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Tsukamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Tsukamoto. The network helps show where Nobuo Tsukamoto may publish in the future.

Co-authorship network of co-authors of Nobuo Tsukamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Tsukamoto. A scholar is included among the top collaborators of Nobuo Tsukamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Tsukamoto. Nobuo Tsukamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression Profiles of Five Common Cancer Membrane Protein Antigens Collected for the Development of Cocktail CAR-T Cell Therapies Applicable to Most Solid Cancer Patients 2025 ·International Journal of Molecular Sciences ·Tetsuya Nakatsura, (unknown), (unknown), Yusuke Ito, Shogo Kikuchi, Hiroki Kinoshita, (unknown), Toshihiro Suzuki, Nobuo Tsukamoto	0
2	Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers 2025 ·Neoplasia ·Hiroki Kinoshita, (unknown), Nobuo Tsukamoto, (unknown), Toshihiro Suzuki, Tetsuya Nakatsura	0
3	Immune-resistant mechanisms in cancer immunotherapy 2020 ·International Journal of Clinical Oncology ·Yutaka Kawakami, Shigeki Ohta, (unknown), Nobuo Tsukamoto, Tomonori Yaguchi	50
4	Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma 2017 ·European Journal of Cancer ·Tomonari Kinoshita, Chie Kudo‐Saito, Reiko Muramatsu, Tomonobu Fujita, Miyuki Saito, (unknown), Toshiharu Sakurai, Shinobu Noji, (unknown), Tomonori Yaguchi, Nobuo Tsukamoto, Yuichiro Hayashi, Kaoru Kaseda, Ikuo Kamiyama, Takashi Ohtsuka, Kenji Tomizawa, Masaki Shimoji, Tetsuya Mitsudomi, Hisao Asamura, Yutaka Kawakami	60
5	CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients 2017 ·Blood Cancer Journal ·Maiko Matsushita, Kyoko Ozawa, Takaya Suzuki, Masaru Nakamura, (unknown), (unknown), Daiju Ichikawa, Eri Matsuki, Masatoshi Sakurai, Daiki Karigane, Hidenori Kasahara, Nobuo Tsukamoto, Takayuki Shimizu, Takehiko Mori, Hideaki Nakajima, Shinichiro Okamoto, Yutaka Kawakami, Yutaka Hattori	12
6	Prognostic value of tumor-infiltrating lymphocytes differs depending on histological type and smoking habit in completely resected non-small-cell lung cancer 2016 ·Annals of Oncology ·Tomonari Kinoshita, Reiko Muramatsu, T. Fujita, (unknown), Toshiharu Sakurai, Shinobu Noji, (unknown), Tomonori Yaguchi, Nobuo Tsukamoto, Chie Kudo‐Saito, Yuichiro Hayashi, Isao Kamiyama, Takashi Ohtsuka, Hisao Asamura, Yutaka Kawakami	127
7	Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy 2013 ·Annals of the New York Academy of Sciences ·Yutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo‐Saito, Nobuo Tsukamoto, (unknown), Shoko Nakamura, Hiroshi Nishio, Ryosuke Satomi, Asuka Kobayashi, (unknown), (unknown), Hajime Kamijuku, Takahiro Tsujikawa, Naoshi Kawamura	17
8	CCL2 is critical for immunosuppression to promote cancer metastasis 2012 ·Clinical & Experimental Metastasis ·Chie Kudo‐Saito, (unknown), (unknown), Nobuo Tsukamoto, Yutaka Kawakami	121
9	Cancer‐testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer 2012 ·Cancer Science ·Koji Okabayashi, Tomonobu Fujita, (unknown), Tsutomu Okada, Takashi Iwata, Nobumaru Hirao, Shinobu Noji, Nobuo Tsukamoto, Naoki Goshima, Hirotoshi Hasegawa, Hiroya Takeuchi, Masakazu Ueda, Yuko Kitagawa, Yutaka Kawakami	28
10	[Immunotherapy targeting cancer stem cells]. 2012 ·PubMed ·Yutaka Kawakami, Maiko Matsushita, Ryo Ueda, Nobuo Tsukamoto, Shigeki Ohta	2
11	Immune Suppression and Resistance Mediated by Constitutive Activation of Wnt/β-Catenin Signaling in Human Melanoma Cells 2012 ·The Journal of Immunology ·Tomonori Yaguchi, Yasufumi Goto, Kenji Kido, Hiroshi Mochimaru, Toshiharu Sakurai, Nobuo Tsukamoto, Chie Kudo‐Saito, Tomonobu Fujita, Hidetoshi Sumimoto, Yutaka Kawakami	125
12	The mechanisms of cancer immunoescape and development of overcoming strategies 2011 ·International Journal of Hematology ·Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo‐Saito, Nobuo Tsukamoto, Ryo Ueda, (unknown), Hiroshi Nishio, Naoshi Kawamura, Yutaka Kawakami	91
13	Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells 2009 ·Clinical Cancer Research ·Nobuo Tsukamoto, (unknown), (unknown), Yusuke Sasaki, Kazuo Umezawa, Yutaka Kawakami	25
14	A Proposal of Temperature Sensing Using a Thin-Film Bandpass Filter and Dual-Wavelength Push–Pull Reflectometry 2008 ·IEEE Photonics Technology Letters ·(unknown), Nobuo Tsukamoto, (unknown), (unknown), (unknown), (unknown), (unknown)	16
15	CCL22 and CCL17 in rat radiation pneumonitis and in human idiopathic pulmonary fibrosis 2004 ·European Respiratory Journal ·Takashi Inoue, Seitaro Fujishima, Eiji Ikeda, Osamu Yoshie, Nobuo Tsukamoto, Sadakazu Aiso, Naoki Aikawa, Atsushi Kubo, Kouji Matsushima, Kazuhiro Yamaguchi	65
16	Altered Gene Expression in the Adult Brain of fyn-Deficient Mice 2004 ·Cellular and Molecular Neurobiology ·June Goto, Tohru Tezuka, Takanobu Nakazawa, Nobuo Tsukamoto, Takahisa Nakamura, Rieko Ajima, Kazumasa Yokoyama, Tsutomu Ohta, Misao Ohki, Tadashi Yamamoto	10
17	Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Family: Adapter Proteins That Mediate Cytokine Signaling 2000 ·Experimental Cell Research ·Jun‐ichiro Inoue, Takaomi Ishida, Nobuo Tsukamoto, Norihiko Kobayashi, Asuka Naito, Sakura Azuma, Tadashi Yamamoto	371
18	Two differently regulated nuclear factor κB activation pathways triggered by the cytoplasmic tail of CD40 1999 ·Proceedings of the National Academy of Sciences ·Nobuo Tsukamoto, Norihiko Kobayashi, Sakura Azuma, Tadashi Yamamoto, Jun‐ichiro Inoue	87
19	Clinical Significance of Positive Blood Cultures in the Nagasaki Rosai Hospital during the Past 6 Years 1994 ·Kansenshogaku zasshi ·Hironori Masaki, Makoto Ide, Hiroyuki Yoshimine, (unknown), Yasuhiro Kawachi, Keiichi Fukuda, Nobuo Tsukamoto, (unknown), Tsuyoshi Nagatake, Kazutsugu Matsumoto	2
20	[Supporting system for CT diagnosis referring to previous cases]. 1993 ·PubMed ·Nobuo Tsukamoto	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact